Profile
TVGN VRTX REGN VRNA ARGX ALNY
Company Name Tevogen Bio Holdings Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $55.34M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.02K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Ryan H. Saadi Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
TVGN VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
TVGN VRTX REGN VRNA ARGX ALNY
Last Close $0.3869 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $1.68 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.39 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -76.97 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low -0.79 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
TVGN VRTX REGN VRNA ARGX ALNY
1 Month Return -44.85 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -59.79 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return -65.76 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -76.26 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -62.44 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -71.55 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
TVGN VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -2199166 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
TVGN VRTX REGN VRNA ARGX ALNY
Asset Growth -37.12 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth -6.67 % 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year - 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth 77.15 % 9.09 % -131.37 % 24.59 %
Net Income Growth 83.28 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 78.81 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share 78.81 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share 78.81 % 680.22 % -35.51 % 55.09 %
Operating Income Growth -505.73 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) -46.84 % - -143.33 % -107.98 %
Operating 3 Year CFG 25.66 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG 25.66 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG 25.66 % -100 % 40.15 % 97.08 %
EPS Growth -23300 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth -23300 % 8.19 % -208.93 % 38.07 %
Book Value Per Share 92.03 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share 86.77 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share 86.77 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 86.77 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth -96.98 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth -44.49 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
TVGN VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -686.47 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM 389.21 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM 1376.93 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 99.37 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 100.48 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -175.25 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.16 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.07 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.07 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 0.53 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -175.25 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -4.19 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -4.08 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -4.08 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
TVGN VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $-0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.01B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.01B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -0.09 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
TVGN VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.01B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $-0.01B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
TVGN VRTX REGN VRNA ARGX ALNY
Net Income $-0.01B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24
AARD Aardvark Therapeutics, Inc. Common Stock 12.61
ABCL AbCellera Biologics Inc. 3.16
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.12
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.47
ABPWW 0.0131
ABSI Absci Corporation 2.64
ABUS Arbutus Biopharma Corporation 4.16
ABVC ABVC BioPharma, Inc. 1.7
ABVX Abivax SA American Depositary Shares 119.18
ACAD ACADIA Pharmaceuticals Inc. 22.7
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 7.13
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.36
ACIU AC Immune SA 3.06
ETFs With Exposure to TVGN
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0 266.16
VTI Vanguard Total Stock Market Index Fund 0.00001 341.8
IBB iShares Biotechnology ETF 0 172.06
IWN iShares Russell 2000 Value ETF 0 200.82
IWO iShares Russell 2000 Growth ETF 0 341.28
BIB ProShares Ultra Nasdaq Biotechnology 0.00420953 84.1278
VXF Vanguard Extended Market Index Fund 0.00004 219.45
HDG ProShares Hedge Replication ETF 0.0000533804 52.7979
UWM ProShares Ultra Russell2000 0.000285421 54.41
IWC iShares Micro-Cap ETF 0 169.95
URTY ProShares UltraPro Russell2000 0.000212456 65.72
VTWV Vanguard Russell 2000 Value Index Fund 0.00024 177.006
OMFS Invesco Russell 2000 Dynamic Multifactor ETF 0.00241 48.28
SMMD iShares Russell 2500 ETF 0 81.28
VTWG Vanguard Russell 2000 Growth Index Fund 0.00036 249.225
VTWO Vanguard Russell 2000 Index Fund 0.00046 107.59
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 50.34
VUN.TO Vanguard U.S. Total Market Index ETF 0.00001 125.94
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00001 118.65
VGRO.TO Vanguard Growth ETF Portfolio 0 44.3
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00001 55.73
VBAL.TO Vanguard Balanced ETF Portfolio 0 37.81
VCNS.TO Vanguard Conservative ETF Portfolio 0 32.08
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.325
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 26.945
IBBQ Invesco Nasdaq Biotechnology ETF 0.005732 29.3123
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01 7.295
VTSAX Vanguard Total Stock Market Index Fund 0.00001 166.35
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01 8.67
SBIO.MI Invesco NASDAQ Biotech UCITS ETF 0.0062 52.13
R2US.L SPDR Russell 2000 US Small Cap UCITS ETF 0.000104 78.52
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00004 166.39
VITSX Vanguard Total Stock Market Index Fund 0.00001 166.38
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.01 8.625
XRS2.F Xtrackers Russell 2000 UCITS ETF 0.00207837 318.35
SC0K.DE Invesco Russell 2000 UCITS ETF 0.0004 115.64
SBIO.L Invesco NASDAQ Biotech UCITS ETF 0.0062 61.97
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00004 166.41
RTYS.L Invesco Russell 2000 UCITS ETF 0.0004 137.58
XRSG.L Xtrackers (IE) Public Limited Company - Xtrackers Russell 2000 UCITS ETF 0.00207837 29157
XRSU.L Xtrackers (IE) Public Limited Company - Xtrackers Russell 2000 UCITS ETF 0.00207837 398.72
ZPRR.DE SPDR Russell 2000 US Small Cap UCITS ETF 0.000104 65.97
R2SC.L SPDR Russell 2000 US Small Cap UCITS ETF 0.000104 57.43
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01 6.355
XRS2.DE Xtrackers Russell 2000 UCITS ETF 0.00207837 335.2
VTS.AX Vanguard US Total Market Shares Index ETF 0.00001 482.09
VEMPX Vanguard Extended Market Index InstlPlus 0.00004 410.63
ITDG iShares Trust 0 39.4501
ITDI iShares Trust 0 39.4096
ITDH iShares Trust 0 39.45
ITDF iShares Trust 0 38.9027
ITDC iShares Trust 0 35.15
ITDB iShares Trust 0 33.84
ITDD Integrated Data Corp. 0 36.63
ITDE iShares Trust 0 37.7759
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00001 312.11
RSSL Global X Funds 0 104.25
ITDJ iShares Trust 0 30.6464
Unlock